Ihab Halaweish1, Ted Bambakidis1, Wei He2, Durk Linzel3, Zhigang Chang4, Ashok Srinivasan5, Simone E Dekker6, Baoling Liu1, Yongqing Li1, Hasan B Alam7. 1. Department of Surgery, University of Michigan Hospital, Ann Arbor, MI. 2. Department of Cardiothoracic Surgery, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China. 3. Department of Emergency Medicine, Flevoziekenhuis Hospital, Almere, The Netherlands. 4. Department of Surgical Critical Care, Beijing Hospital Ministry of Health, Beijing, China. 5. Department of Radiology, Section of Neuroradiology, University of Michigan Hospital, Ann Arbor, MI. 6. Department of Anesthesiology, VU University Medical Center, Institute for Cardiovascular Research, Amsterdam, The Netherlands. 7. Department of Surgery, University of Michigan Hospital, Ann Arbor, MI. Electronic address: alamh@med.umich.edu.
Abstract
BACKGROUND: We have shown that early administration of fresh frozen plasma (FFP) reduces the size of brain lesions 6 hours after injury in a large animal model of traumatic brain injury (TBI) and hemorrhagic shock (HS). To examine long-term outcomes, we hypothesized that early treatment with FFP would result in faster neurologic recovery and better long-term outcomes in a combined TBI and HS model. STUDY DESIGN: Anesthetized Yorkshire swine underwent combined TBI and volume-controlled hemorrhage (40% blood volume). After 2 hours of shock, animals were randomized (n = 5/group) to normal saline (3× shed blood) or FFP (1× shed blood) treatment. A neurologic severity score was assessed for 30 days. Magnetic resonance imaging of the brain was performed at days 3, 10, and 24. Cognitive function was tested by training animals to retrieve food from color-coded boxes. RESULTS: Neurologic impairment was lower and speed of recovery was considerably faster in the FFP-treated animals. There was a trend toward a smaller lesion size in FFP-treated animal at days 3 and 10, but this did not reach statistical significance. Both groups reached baseline performance on the cognitive testing; however, FFP-treated animals were able to participate, on average, 8 days earlier due to quicker recovery. CONCLUSIONS: This is the first study to demonstrate the beneficial effects of FFP treatment in a long-term survival model of combined TBI and HS. Our data show that early treatment with FFP substantially attenuates the degree of neurologic impairment, improves the rate of recovery, and preserves the cognitive functions.
BACKGROUND: We have shown that early administration of fresh frozen plasma (FFP) reduces the size of brain lesions 6 hours after injury in a large animal model of traumatic brain injury (TBI) and hemorrhagic shock (HS). To examine long-term outcomes, we hypothesized that early treatment with FFP would result in faster neurologic recovery and better long-term outcomes in a combined TBI and HS model. STUDY DESIGN: Anesthetized Yorkshire swine underwent combined TBI and volume-controlled hemorrhage (40% blood volume). After 2 hours of shock, animals were randomized (n = 5/group) to normal saline (3× shed blood) or FFP (1× shed blood) treatment. A neurologic severity score was assessed for 30 days. Magnetic resonance imaging of the brain was performed at days 3, 10, and 24. Cognitive function was tested by training animals to retrieve food from color-coded boxes. RESULTS:Neurologic impairment was lower and speed of recovery was considerably faster in the FFP-treated animals. There was a trend toward a smaller lesion size in FFP-treated animal at days 3 and 10, but this did not reach statistical significance. Both groups reached baseline performance on the cognitive testing; however, FFP-treated animals were able to participate, on average, 8 days earlier due to quicker recovery. CONCLUSIONS: This is the first study to demonstrate the beneficial effects of FFP treatment in a long-term survival model of combined TBI and HS. Our data show that early treatment with FFP substantially attenuates the degree of neurologic impairment, improves the rate of recovery, and preserves the cognitive functions.
Authors: Matthew C Hernandez; Cornelius A Thiels; Johnathon M Aho; Elizabeth B Habermann; Martin D Zielinski; James A Stubbs; Donald H Jenkins; Scott P Zietlow Journal: J Trauma Acute Care Surg Date: 2017-09 Impact factor: 3.313
Authors: Vahagn C Nikolian; Baihong Pan; Tomaz Mesar; Isabel S Dennahy; Patrick E Georgoff; Xiuzhen Duan; Baoling Liu; Xizi Wu; Michael J Duggan; Hasan B Alam; Yongqing Li Journal: Inflammation Date: 2017-08 Impact factor: 4.092
Authors: Ronald Chang; Lindley E Folkerson; Duncan Sloan; Jeffrey S Tomasek; Ryan S Kitagawa; H Alex Choi; Charles E Wade; John B Holcomb Journal: Surgery Date: 2016-10-21 Impact factor: 3.982
Authors: Samuel M Galvagno; Erin E Fox; Savitri N Appana; Sarah Baraniuk; Patrick L Bosarge; Eileen M Bulger; Rachel A Callcut; Bryan A Cotton; Michael Goodman; Kenji Inaba; Terence O'Keeffe; Martin A Schreiber; Charles E Wade; Thomas M Scalea; John B Holcomb; Deborah M Stein Journal: J Trauma Acute Care Surg Date: 2017-06-06 Impact factor: 3.313
Authors: Simone E Dekker; Vahagn C Nikolian; Martin Sillesen; Ted Bambakidis; Patrick Schober; Hasan B Alam Journal: J Neurosci Res Date: 2017-07-25 Impact factor: 4.164
Authors: Andrew R Mayer; Andrew B Dodd; Meghan S Vermillion; David D Stephenson; Irshad H Chaudry; Denis E Bragin; Andrew P Gigliotti; Rebecca J Dodd; Benjamin C Wasserott; Priyank Shukla; Rachel Kinsler; Sheila M Alonzo Journal: Neurosci Biobehav Rev Date: 2019-06-27 Impact factor: 8.989
Authors: Glenn K Wakam; Ben E Biesterveld; Manjunath P Pai; Michael T Kemp; Rachel L O'Connell; Krishani K Rajanayake; Kiril Chtraklin; Claire A Vercruysse; Hasan B Alam Journal: J Trauma Acute Care Surg Date: 2021-11-01 Impact factor: 3.313
Authors: Erika Gonzalez Rodriguez; Jessica C Cardenas; Charles S Cox; Ryan S Kitagawa; Jakob Stensballe; John B Holcomb; Pär I Johansson; Charles E Wade Journal: Scand J Trauma Resusc Emerg Med Date: 2018-11-21 Impact factor: 2.953